New Partnership for Comprehensive In Vitro Cardiac Safety Assessment

PhysioStim & ACEA Biosciences announce partnershipA hi-tech alliance to measure preclinical cardiac safety in vitroACEA Biosciences and PhysioStim will work together to provide comprehensive in vitro cardiac safety and toxicity assessment services for pharmaceutical and biotechnology companies in Europe.Press release ACEA Biosciences Inc. (ACEA), now a part of Agilent Technologies, is a pioneer in the development and commercialization of high
Read more